After Three Strikes, Relmada Abandons Depression Drug Esmethadone
The development saga for the depression molecule has been rocky for years, unable to ease symptoms in multiple late-stage trials.
After Three Strikes, Relmada Abandons Depression Drug Esmethadone Read More »
